CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | Houghton Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-05-25 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-05-25 | ALTIG ANTHONY E Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-05-23 | McHutchison John G Director | Sale | −25,972 | $1.04 | $27K | 169,160 |
| 2023-05-23 | Bjorkquist Jeanette M Principal Accounting Officer | Sale | −274 | $1.04 | $285 | 27,532 |
| 2023-05-23 | Delaney William E IV Chief Scientific Officer | Sale | −6,561 | $1.04 | $7K | 116,437 |
| 2023-05-23 | Okazaki Jason A CEO and President | Sale | −6,561 | $1.04 | $7K | 126,613 |
| 2023-05-22 | McHutchison John G Director | Grant or award | +117,500 | 295,132 | ||
| 2023-05-22 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award | +1,500 | 27,806 | ||
| 2023-05-22 | Delaney William E IV Chief Scientific Officer | Grant or award | +35,000 | 122,998 | ||
| 2023-05-22 | Okazaki Jason A CEO and President | Grant or award | +35,000 | 133,174 | ||
| 2023-03-30 | McHutchison John G Director | Sale | −14,883 | $0.82 | $12K | 177,632 |
| 2023-03-30 | Bjorkquist Jeanette M Principal Accounting Officer | Sale | −774 | $0.82 | $637 | 23,806 |
| 2023-03-30 | Delaney William E IV Chief Scientific Officer | Sale | −3,421 | $0.82 | $3K | 85,498 |
| 2023-03-30 | Okazaki Jason A CEO and President | Sale | −4,247 | $0.82 | $3K | 98,174 |
| 2023-03-29 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award | +6,250 | 24,580 | ||
| 2023-03-29 | Bjorkquist Jeanette M Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2023-03-29 | Okazaki Jason A CEO and President | Grant or award · Stock Option (right to buy) | +470,000 | 470,000 | ||
| 2023-03-27 | Okazaki Jason A CEO and President | Sale | −4,693 | $1.02 | $5K | 102,421 |
Page 7 of 15 · 297 trades